Möhn, N.; Konen, F.F.; Pul, R.; Kleinschnitz, C.; Prüss, H.; Witte, T.; Stangel, M.; Skripuletz, T.
Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases. J. Clin. Med. 2020, 9, 4067.
https://doi.org/10.3390/jcm9124067
AMA Style
Möhn N, Konen FF, Pul R, Kleinschnitz C, Prüss H, Witte T, Stangel M, Skripuletz T.
Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases. Journal of Clinical Medicine. 2020; 9(12):4067.
https://doi.org/10.3390/jcm9124067
Chicago/Turabian Style
Möhn, Nora, Franz F. Konen, Refik Pul, Christoph Kleinschnitz, Harald Prüss, Torsten Witte, Martin Stangel, and Thomas Skripuletz.
2020. "Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases" Journal of Clinical Medicine 9, no. 12: 4067.
https://doi.org/10.3390/jcm9124067
APA Style
Möhn, N., Konen, F. F., Pul, R., Kleinschnitz, C., Prüss, H., Witte, T., Stangel, M., & Skripuletz, T.
(2020). Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases. Journal of Clinical Medicine, 9(12), 4067.
https://doi.org/10.3390/jcm9124067